Maine has emerged as a hotspot for type 1 diabetes, recording the highest incidence rate in the United States, according to new state-by-state data. The state's rate stands at 27.4 cases per 100,000 people, exceeding the national average of 24.0.
Other Northeastern states such as Vermont and New Hampshire also ranked among the top five highest incidence rates, alongside West Virginia and Kentucky. Conversely, Hawaii, New Mexico, and California reported the lowest rates of the condition.
While most individuals in the U.S. diagnosed with diabetes have type 2, a condition where the body struggles to regulate blood sugar due to insulin resistance, an increasing number are being diagnosed with type 1 diabetes. Type 1 diabetes occurs when the immune system mistakenly destroys the body's insulin-producing cells.
The precise causes of type 1 diabetes remain unclear, though researchers suggest that a combination of genetic predisposition, particularly among individuals of white ethnic background, and environmental factors like viral exposures may contribute to its development. The latest data, published in JAMA Network Open, analyzed incidence rates for type 1 diabetes nationwide in 2024.
Nationwide, an estimated 2.07 million Americans are living with type 1 diabetes, a figure projected to increase by 10 percent by 2033. Annually, over 60,000 new cases are diagnosed, with approximately half of these occurring in adults, most commonly between the ages of 45 and 64.
When comparing states, West Virginia recorded the highest incidence rate at 27.8 per 100,000, though researchers note this figure is based on a smaller population. Maine and Vermont followed closely with 27.4 cases per 100,000. New Hampshire reported a rate of 26.9, and Kentucky had 26.8. Maine and West Virginia are considered statistically tied for the highest rate.
At the lower end of the spectrum, Hawaii reported the lowest incidence rate at 17.0 per 100,000. New Mexico's rate was 20.5, California's was 20.6, Alaska's was 20.9, and Arizona's was 22.5.
Separate data focusing on the prevalence—the total number of people living with the disease—for 2024 indicated that California and Texas had the highest rates, which is attributed to their large overall patient populations.
Regarding demographic factors, over 70 percent of type 1 diabetes cases are diagnosed in white adults. Hispanic individuals account for 15 percent of cases, and Black and Asian individuals each represent about 10 percent. Maine, which has the highest proportion of white residents in the U.S. at 90 percent, followed by West Virginia and Vermont at 89 percent, aligns with this demographic trend.
Researchers are exploring several potential factors that could explain the higher incidence rates in certain populations and geographic areas. One theory suggests a genetic link, possibly involving mutations on the HLA-DR3 or HLA-DR4 genes, which are associated with autoimmune diseases and may increase the likelihood of the immune system attacking insulin-producing cells. Environmental exposures, such as infections from enteroviruses, have also been implicated, though not as a direct cause but potentially as triggers in genetically susceptible individuals.
Other hypotheses include the 'hygiene hypothesis,' which posits that reduced exposure to microbes in early life might disrupt immune system development, increasing the risk of autoimmune conditions. Additionally, studies on mice have suggested that antibiotic exposure during critical developmental periods could impair insulin-producing cells, while certain fungi might promote their growth and reduce diabetes risk.
The geographic distribution, with higher rates observed at greater distances from the equator, has led to investigations into vitamin D deficiency as a contributing factor. Vitamin D plays a role in immune regulation, and its deficiency might allow autoimmune responses to proceed unchecked. Some research suggests that adequate vitamin D levels during pregnancy or early childhood could lower risk.
The 'accelerator hypothesis' posits that obesity and insulin resistance might hasten the destruction of insulin-producing cells. Environmental chemicals, including phthalates and heavy metals, are also being examined for their potential to disrupt immune and hormonal systems.
In their findings, the researchers also highlighted a need for more pediatric endocrinologists across the country.